Insider sale
PASSAGE BIO, INC.
$441.6K
1.24M shares
ORBIMED ADVISORS LLC plans to sell 1.24M shares of PASSAGE BIO, INC. valued at approximately $441.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
IPO
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2020 | IPO N/A | 259K | — |
| Total | 259K | ||
Completed
Units to sell
11.04K
Market value
$3.8K
Units to sell
213.26K
Market value
$70.4K
Units to sell
138.80K
Market value
$45.8K
Units to sell
231.60K
Market value
$81.1K
Units to sell
68.19K
Market value
$21.8K
Units to sell
89.33K
Market value
$30.4K
Units to sell
78.05K
Market value
$26.5K
Units to sell
77.09K
Market value
$25.4K
Units to sell
61.64K
Market value
$20.3K
Units to sell
10.33K
Market value
$3.9K
Planned — Approximate Date
Units to sell
259K
Market value
$112.1K
Units
1.24M
Value
$441.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/27/2025 | 11.04K | $3.8K | — | Completed |
6/26/2025 | 213.26K | $70.4K | — | Completed |
6/25/2025 | 138.80K | $45.8K | — | Completed |
6/24/2025 | 231.60K | $81.1K | — | Completed |
4/24/2025 | 68.19K | $21.8K | — | Completed |
4/23/2025 | 89.33K | $30.4K | — | Completed |
4/22/2025 | 78.05K | $26.5K | — | Completed |
4/17/2025 | 77.09K | $25.4K | — | Completed |
4/16/2025 | 61.64K | $20.3K | — | Completed |
4/15/2025 | 10.33K | $3.9K | — | Completed |
| Planned — Approximate Date | ||||
7/7/2025 | 259K | $112.1K | Nasdaq Stock Market | Planned |
| Total | 1.24M | $441.6K | ||